Deutsch English Français

Contact

EP0839798

European procedure

Quick help

Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...

News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...

Extract from the Register of European Patents

EP About this file: EP0839798

EP0839798 - Intermediates for preparating non-peptide retroviral protease inhibitors [Right-click to bookmark this link]
Status	No opposition filed within time limit Status updated on 23.06.2006 Database last updated on 24.08.2024
Most recent event Tooltip	23.06.2006	No opposition filed within time limit	published on 26.07.2006 [2006/30]
Applicant(s)	For all designated states ABBOTT LABORATORIES One Abbott Park Road Abbott Park IL 60064-3500 / US
	[N/P]
Former [1998/19]	For all designated states ABBOTT LABORATORIES One Abbott Park Road Abbott Park, Illinois 60064-3500 / US
Inventor(s)	01 / Kempf, Dale J. 256 Tyler Court Libertyville, Illinois 60048 / US
	02 / Norbeck, Daniel W. 2810 Federal Court Crystal Lake Illinois 60012 / US
	03 / Erickson, John W. 725 Seventh Street Summitt Barrington, Illinois 60010 / US
	04 / Sham, Hing Leung 5109 Pembrook Court Gurnee, Illinois 60031 / US
	05 / Codacovi, Lynn M. 40024 North Circle Antioch, Illinois 60002 / US
	06 / Plattner, Jacob J. 1016 Amito Avenue Berkeley, California 94705 / US
	[1998/39]
Former [1998/19]	01 / Kempf, Dale J. 205 Chelsea Circle Lake Villa, Illinois 60046 / US
	02 / Norbeck, Daniel W. 307 Hazelwood Lindenhurst, Illinois 60046 / US
	03 / Erickson, John W. 725 Seventh Street Summitt Barrington, Illinois 60010 / US
	04 / Sham, Hing Leung 5109 Pembrook Court Gurnee, Illinois 60031 / US
	05 / Codacovi, Lynn M. 40024 North Circle Antioch, Illinois 60002 / US
	06 / Plattner, Jacob J. 1301 St. William Drive Libertyville, Illinois 60048 / US
Representative(s)	Modiano, Micaela Nadia Modiano Josif Pisanty & Staub Ltd Thierschstrasse 11 80538 München / DE
	[N/P]
Former [2005/45]	Modiano, Micaela Nadia Modiano, Josif, Pisanty & Staub Ltd., Baaderstrasse 3 80469 München / DE
Former [1998/19]	Modiano, Guido, Dr.-Ing., et al Modiano, Josif, Pisanty & Staub, Baaderstrasse 3 80469 München / DE
Application number, filing date	97119700.9	17.05.1990
	[1998/19]
Priority number, date	US19890355945	23.05.1989 Original published format: US 355945
	US19890405604	08.09.1989 Original published format: US 405604
	US19890456124	22.12.1989 Original published format: US 456124
	US19900518730	09.05.1990 Original published format: US 518730
	[1998/19]
Filing language	EN
Procedural language	EN
Publication	Type:	A2 Application without search report
	No.:	EP0839798
	Date:	06.05.1998
	Language:	EN
	[1998/19]
	Type:	A3 Search report
	No.:	EP0839798
	Date:	28.10.1998
	[1998/44]
	Type:	B1 Patent specification
	No.:	EP0839798
	Date:	17.08.2005
	Language:	EN
	[2005/33]
Search report(s)	(Supplementary) European search report - dispatched on:	EP	28.08.1998
Classification	IPC:	C07C215/18, C07C271/20, C07C237/10, C07D303/40, C07D303/46	[1998/19]
	CPC:	C07D207/08 (EP,US); C07K5/04 (KR); A61P31/12 (EP); A61P37/04 (EP); C07C211/27 (EP,US); C07C215/18 (EP,US); (+) C07C215/20 (EP,US); C07C215/28 (EP,US); C07C229/08 (EP,US); C07C229/26 (EP,US); C07C229/34 (EP,US); C07C233/36 (EP,US); C07C233/40 (EP,US); C07C235/10 (EP,US); C07C235/12 (EP,US); C07C235/34 (EP,US); C07C235/78 (EP,US); C07C237/10 (EP,US); C07C237/20 (EP,US); C07C237/22 (EP,US); C07C239/10 (EP,US); C07C239/18 (EP,US); C07C239/20 (EP,US); C07C247/10 (EP,US); C07C251/40 (EP,US); C07C271/20 (EP,US); C07C271/22 (EP,US); C07C271/34 (EP,US); C07C275/16 (EP,US); C07C275/24 (EP,US); C07C311/03 (EP,US); C07C311/13 (EP,US); C07C311/18 (EP,US); C07C317/10 (EP,US); C07C317/28 (EP,US); C07C317/44 (EP,US); C07C323/12 (EP,US); C07C323/25 (EP,US); C07C33/46 (EP,US); C07C381/00 (EP,US); C07C43/164 (EP,US); C07C43/1742 (EP,US); C07C43/2055 (EP,US); C07C43/215 (EP,US); C07C43/23 (EP,US); C07C43/30 (EP,US); C07C43/315 (EP,US); C07C45/004 (EP,US); C07C45/29 (EP,US); C07C45/567 (EP,US); C07C45/59 (EP,US); C07C45/62 (EP,US); C07C45/673 (EP,US); C07C45/74 (EP,US); C07C53/134 (EP,US); C07C69/34 (EP,US); C07C69/65 (EP,US); C07C69/732 (EP,US); C07D207/24 (EP,US); C07D209/42 (EP,US); C07D211/62 (EP,US); C07D213/30 (EP,US); C07D213/40 (EP,US); C07D213/42 (EP,US); C07D213/56 (EP,US); C07D213/70 (EP,US); C07D213/81 (EP,US); C07D213/82 (EP,US); C07D215/16 (EP,US); C07D217/16 (EP,US); C07D217/26 (EP,US); C07D231/12 (EP,US); C07D233/56 (EP,US); C07D233/84 (EP,US); C07D239/38 (EP,US); C07D249/08 (EP,US); C07D263/32 (EP,US); C07D277/24 (EP,US); C07D277/28 (EP,US); C07D277/36 (EP,US); C07D277/42 (EP,US); C07D277/56 (EP,US); C07D295/088 (EP,US); C07D295/15 (EP,US); C07D295/155 (EP,US); C07D295/185 (EP,US); C07D295/205 (EP,US); C07D295/215 (EP,US); C07D295/26 (EP,US); C07D303/04 (EP,US); C07D303/22 (EP,US); C07D303/36 (EP,US); C07D303/48 (EP,US); C07D307/42 (EP,US); C07D317/12 (EP,US); C07D413/12 (EP,US); C07D417/12 (EP,US); C07D487/04 (EP,US); C07F9/3241 (EP,US); C07F9/5333 (EP,US); C07K5/021 (EP,US); C07K5/06043 (EP,US); C07K5/06052 (EP,US); C07K5/06139 (EP,US); A61K38/00 (EP,US); C07C2601/14 (EP,US); Y02P20/55 (EP,US) (-)
	C-Set:	C07C45/004, C07C49/233 (US,EP); C07C45/29, C07C49/255 (US,EP); C07C45/567, C07C49/215 (US,EP); C07C45/59, C07C49/245 (US,EP); (+) C07C45/62, C07C49/215 (EP,US); C07C45/673, C07C49/245 (EP,US); C07C45/74, C07C49/223 (EP,US); C07C45/74, C07C49/235 (EP,US); C07C45/74, C07C49/255 (EP,US) (-)
Designated contracting states	AT, BE, CH, DE, DK, ES, FR, GB, GR, IT, LI, LU, NL, SE [1998/19]
Title	German:	Zwischenprodukte zur Herstellung von non-peptiden retroviralproteasehemmenden Verbindungen	[1998/19]
	English:	Intermediates for preparating non-peptide retroviral protease inhibitors	[1998/19]
	French:	Produits intermédiaires pour la préparation d'inhibiteurs de proteases retrovirales non-peptidiques	[1998/19]
Examination procedure	22.03.1999	Examination requested [1999/20]
	18.12.2002	Despatch of a communication from the examining division (Time limit: M06)
	30.05.2003	Reply to a communication from the examining division
	06.05.2004	Despatch of a communication from the examining division (Time limit: M06)
	10.11.2004	Reply to a communication from the examining division
	18.01.2005	Communication of intention to grant the patent
	18.04.2005	Fee for grant paid
	18.04.2005	Fee for publishing/printing paid
Parent application(s) Tooltip	EP90109319.5 / EP0402646
Opposition(s)	18.05.2006	No opposition filed within time limit [2006/30]
Fees paid	Renewal fee
	27.11.1997	Renewal fee patent year 03
	27.11.1997	Renewal fee patent year 04
	27.11.1997	Renewal fee patent year 05
	27.11.1997	Renewal fee patent year 06
	27.11.1997	Renewal fee patent year 07
	27.11.1997	Renewal fee patent year 08
	24.04.1998	Renewal fee patent year 09
	06.05.1999	Renewal fee patent year 10
	08.05.2000	Renewal fee patent year 11
	10.05.2001	Renewal fee patent year 12
	06.05.2002	Renewal fee patent year 13
	07.05.2003	Renewal fee patent year 14
	05.05.2004	Renewal fee patent year 15
	13.05.2005	Renewal fee patent year 16
Opt-out from the exclusive Tooltip competence of the Unified Patent Court	See the Register of the Unified Patent Court for opt-out data
	Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:	Search	[A]EP0275101 (MERRELL DOW PHARMA [US]) [A] 1 * page 16 - page 19; example VB *;
		[A] - A. DURÉAULT ET AL., "Diastereospecific synthesis of Diaziridines from D-Mannitol. Access to chiral alpha-aminoacids", TETRAHEDRON LETTERS, GREAT BRITAIN, (1986), vol. 27, no. 35, pages 4157 - 4160, XP002071570 [A] 1 * the whole document * DOI: http://dx.doi.org/10.1016/S0040-4039(00)84935-7

The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.

Legal notice
Terms of use
24.2.25; 34p